Scientists Are Discovering GLP-1s Help More Than Weight — Knees, Kidneys, Sleep, and More

If You Feel Conflicted About Taking a "Weight Loss Drug" — Read This

Many people who could benefit from GLP-1 medications hesitate because they think of them as "just" weight-loss drugs, and they are not sure weight loss alone justifies taking a medication long-term. Here is why that framing is outdated: GLP-1 medications are increasingly being recognized as multi-system medications that protect your heart, your kidneys, your joints, and possibly even your brain.

What Is Proven

Heart Protection

Semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 20% in people with obesity and heart disease. This is not theoretical — it was demonstrated in the SELECT trial of over 17,000 patients and led to a formal FDA indication for cardiovascular risk reduction.

Kidney Protection

The FLOW trial was stopped early because semaglutide was so effective at protecting kidney function in patients with type 2 diabetes and chronic kidney disease. The benefits were independent of weight loss — the drug appears to directly protect kidney tissue.

What Is Promising

Joint Pain and Osteoarthritis

Research has found that patients on semaglutide experience meaningful reductions in knee pain. Part of this is mechanical — every pound you lose removes about four pounds of pressure from your knees. But researchers are also investigating whether GLP-1s have direct anti-inflammatory effects on joint tissue.

Sleep Apnea

Weight loss from GLP-1 therapy reduces fat deposits around the airway, improving breathing during sleep. Many patients report better sleep quality within the first few months of treatment.

Addiction and Substance Cravings

As covered in our companion article, clinical trials and large observational studies suggest GLP-1s may reduce cravings for alcohol and other substances. 33 clinical trials are currently investigating this connection.